Robert Aspbury
Corporate Officer/Principal at CERTARA, INC.
Net worth: 5 M $ as of 2024-04-29
Profile
Robert P.
Aspbury is currently the President-Certara Scientific Software at Certara, Inc. Prior to his current position, he worked as the Vice President-Strategic Solutions at Labcorp Drug Development, Inc. from 2016 to 2019.
He holds a doctorate degree from The University of Liverpool, which he obtained in 1995.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CERTARA, INC.
0.18% | 2024-03-31 | 290,176 ( 0.18% ) | 5 M $ | 2024-04-29 |
Robert Aspbury active positions
| Companies | Position | Start |
|---|---|---|
| CERTARA, INC. | Corporate Officer/Principal | 2019-12-31 |
Former positions of Robert Aspbury
| Companies | Position | End |
|---|---|---|
| COVANCE INC. | Corporate Officer/Principal | 2019-02-28 |
Training of Robert Aspbury
| The University of Liverpool | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Private companies | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Robert Aspbury